相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The impact of epidermal growth factor receptor mutation status on adjuvant chemotherapy for patients with high-risk stage I lung adenocarcinoma
Yasuhiro Tsutani et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2022)
Prognostic factors for relapse-free survival in stage IB-IIIA primary lung adenocarcinoma by epidermal growth factor receptor mutation status
Tetsuya Isaka et al.
BMC CANCER (2022)
Phase III study of adjuvant gemcitabine compared with adjuvant uracil-tegafur in patients with completely resected pathological stage IB-IIIA non-small cell lung cancer (WJTOG0101)
Masafumi Yamaguchi et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2021)
Thoracic and cardiovascular surgeries in Japan during 2017 Annual report by the Japanese Association for Thoracic Surgery
Hideyuki Shimizu et al.
GENERAL THORACIC AND CARDIOVASCULAR SURGERY (2020)
Osimertinib in Resected EGFR-Mutated Non-Small-Cell Lung Cancer
Yi-Long Wu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Demographics, Safety and Quality, and Prognostic Information in Both the Seventh and Eighth Editions of the TNM Classification in 18,973 Surgical Cases of the Japanese Joint Committee of Lung Cancer Registry Database in 2010
Jiro Okami et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
J. Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
A Multicenter Randomized Controlled Study of Paclitaxel plus Carboplatin versus Oral Uracil-Tegafur as the Adjuvant Chemotherapy in Resected Non-Small Cell Lung Cancer
Shinichi Toyooka et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
Effect of Postoperative Adjuvant Chemotherapy with Tegafur-Uracil on Survival in Patients with Stage IA Non-small Cell Lung Cancer An Exploratory Analysis from a Meta-Analysis of Six Randomized Controlled Trials
Chikuma Hamada et al.
JOURNAL OF THORACIC ONCOLOGY (2009)
Lung Adjuvant Cisplatin Evaluation: A pooled analysis by the LACE collaborative group
Jean-Pierre Pignon et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Randomised study of adjuvant chemotherapy for completely resected p-stage I-IIIA non-small cell lung cancer
K. Nakagawa et al.
BRITISH JOURNAL OF CANCER (2006)
Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial
Jean-Yves Douillard et al.
LANCET ONCOLOGY (2006)
Postoperative adjuvant cisplatin, vindesine, plus uracil-tegafur chemotherapy increased survival of patients with completely resected p-stage I non-small cell lung cancer
M Imaizumi
LUNG CANCER (2005)
Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer
T Winton et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
A randomized phase III trial of adjuvant chemotherapy with UFT for completely resected pathological stage I non-small-cell lung cancer: the West Japan Study Group for Lung Cancer Surgery (WJSG) - the 4th study
M Nakagawa et al.
ANNALS OF ONCOLOGY (2005)
A randomized trial of postoperative UFT therapy in p stage I, II non-small cell lung cancer: North-east Japan Study Group for Lung Cancer Surgery
C Endo et al.
LUNG CANCER (2003)
分享论文
